
|Articles|March 7, 2019
European Medical Device Company Signs Agreement to Use OmniComm’s TrialMaster
Advertisement
OmniComm Systems, Inc., a global provider of clniical data management technology, announced that a major European medical device company specializing in ophthalmology has signed a three-year agreement to use it's TrialMaster EDC. The medical device company will use TrialMaster to build and manage multiple clinical studies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5






.png)



.png)



.png)
.png)
